Handelsbanken Fonder’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.07M | Hold |
32,300
| – | – | ﹤0.01% | 931 |
|
|
2025
Q1 | $1.3M | Hold |
32,300
| – | – | 0.01% | 834 |
|
|
2024
Q4 | $1.52M | Buy |
32,300
+2,900
| +10% | +$136K | 0.01% | 784 |
|
|
2024
Q3 | $1.55M | Buy |
29,400
+5,900
| +25% | +$311K | 0.01% | 752 |
|
|
2024
Q2 | $1.27M | Buy |
23,500
+800
| +4% | +$43.3K | 0.01% | 735 |
|
|
2024
Q1 | $1.59M | Buy |
22,700
+2,900
| +15% | +$203K | 0.01% | 671 |
|
|
2023
Q4 | $1.65M | Buy |
19,800
+2,400
| +14% | +$200K | 0.01% | 604 |
|
|
2023
Q3 | $513K | Hold |
17,400
| – | – | ﹤0.01% | 1041 |
|
|
2023
Q2 | $568K | Buy |
17,400
+4,800
| +38% | +$157K | ﹤0.01% | 1000 |
|
|
2023
Q1 | $443K | Hold |
12,600
| – | – | ﹤0.01% | 1059 |
|
|
2022
Q4 | $577K | Buy |
12,600
+800
| +7% | +$36.6K | ﹤0.01% | 883 |
|
|
2022
Q3 | $572K | Hold |
11,800
| – | – | ﹤0.01% | 884 |
|
|
2022
Q2 | $464K | Hold |
11,800
| – | – | ﹤0.01% | 1069 |
|
|
2022
Q1 | $434K | Sell |
11,800
-4,700
| -28% | -$173K | ﹤0.01% | 1304 |
|
|
2021
Q4 | $752K | Hold |
16,500
| – | – | ﹤0.01% | 1070 |
|
|
2021
Q3 | $590K | Hold |
16,500
| – | – | ﹤0.01% | 1243 |
|
|
2021
Q2 | $327K | Buy |
16,500
+1,100
| +7% | +$21.8K | ﹤0.01% | 1607 |
|
|
2021
Q1 | $358K | Hold |
15,400
| – | – | ﹤0.01% | 1369 |
|
|
2020
Q4 | $320K | Buy |
+15,400
| New | +$320K | ﹤0.01% | 1373 |
|